Skip to main content

How is Grouping of Controlled Substances Carried Out?

Controlled substances are basically medications which can form the basis for physical and mental dependency. Therefore, the process of manufacturing, custody and use of such medications is controlled by law. It should be known that controlled substances are planned and classified by a specific authority known as the Drug Enforcement Administration (DEA). At present, the most common examples of controlled substances cover opioid pain medications such as Vicodin. Furthermore, ADHD medications like Adderall are also included in this category.


Do you known how controlled substances are classified?

Drug classifications prove beneficial in categorizing current as well as developing drugs, thereby, helping law enforcers, policymakers and medical experts recognize the best ways to handle a certain substance. Based on this practice, programming narcotics, prescription medications as well as other drugs tends to make the overall industry a safer arena for everyone.

Safety Classification by DEA and Food and Drug Administration (FDA)

It is essential to known that various readings on the drug’s effectiveness and associated risks are necessary to be reviewed. To be precise, any new drug planning to enter the market is mandatory to be analyzed. In order to recruit a schedule, the DEA first examines if the drug can be ill-treated or not. If the chances are slightly higher, then it is immediately put for a schedule. Post this stage, the drug's medical value along with relative prospective to get abused are evaluated in order to place it on the schedule.

Considering the controlled substance market,  Schedule  1 drugs hold no medical value and are known to possess high abuse potential. Whereas, schedule 2 till 5 substances do consist some medical value; however, differ in ranking based on their abuse potential.

Below mentioned are few examples of drugs which are listed on each schedule:

Schedule 1- Heroin, LSD, Ecstasy and Marijuana
Schedule 2- Morphine, Cocaine, Adderall, Ritalin, Vicodin and Oxycodone
Schedule 3-Anabolic steroids, testosterone and Tylenol with codeine
Schedule 4- Valium, Soma, Ambien and Xanax
Schedule 5- Cough Suppressants and Lyrica
Labels:

Comments

Post a Comment

Popular posts from this blog

Electrosurgery Devices Market: Radiofrequency Electrosurgery Devices will Remain the Top-Selling Product

On the back of rising ageing population, increased instances of surgical procedures and technological innovations, the market for electrosurgical devices is likely to slate lucrative growth triggers in the coming years. Significant spike in surgical procedures pertaining neurology, cardiology, gynecology, and several other general surgeries, electrosurgery devices market is in the cusp of exponential growth. Owing to technological innovations the electrosurgery market in North America has demonstrated growth traction over the years. However, increased healthcare spending towards minimally invasive treatment in Asia-Pacific region is expected to propel the market forward, thus contributing as one of the fastest regional hub in electrosurgery devices market. However, factors such as significant product recalls owing to incompliance with FDA framework remain potential challenges for the growth trajectory. Get sample of this report at https://www.factmr.com/connectus/sample?flag=S...
Post a Comment
Read more

North America to Maintain its Leader Status for the Dermatology Devices Market

 Increasing geriatric population across the world have propelled the demand for the dermatology devices, which in turn has contributed to the growth of the dermatology devices market. Rising adoption of dermatology devices in parallel to the rapid adoption of technology in the dermatology clinics and hospitals for treating skin disorders have been prominent factors for the growth of dermatology devices market. Spur in the spending capability of consumers have facilitated the access to these devices. Pervasiveness of skin disorders has been rising at the global level, which has created demand for acute treatment devices. Developments in the treatment methodologies such as liposuction devices and laser instruments have been successful in attracting the attention of the consumers. A recent report published by Fact.MR states that the global dermatology devices market is anticipated to surpass the whopping value of US$ 1,000 Mn by 2022. Browse Full Report with TOC 'https://www.factm...
Post a Comment
Read more

Lithotripsy Devices Market: Non-Invasive ESWL Witnessing Immense Traction

The report offers a crisp overview of the lithotripsy devices market, which includes an introduction to the lithotripsy devices market in tandem with a definition of the target product – lithotripsy devices. A systematic breakdown of the lithotripsy devices market has been offered in this chapter, which implies scope of the research involved. Size of lithotripsy devices market has been studied in terms of volume (tons) and value (MN), and forecast on the lithotripsy devices market has been offered for the period between 2018 and 2026. The lithotripsy devices market is projected to continue its steady growth due to the burgeoning cases of kidney stones, coupled with the surging demand for minimally invasive medical treatments. According to Fact.MR report, the  lithotripsy devices market  is anticipated to accelerate at 4.3% CAGR during 2018-2026 to reach a value of US$ 1,095.2 MN by the end of 2026. In recent past, lithotripsy has become the most pref...
Post a Comment
Read more